Nabumetone Tablet, Film Coated
Product Images NDC 0591-3671
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 0591-3671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
Image 4
Print Medication Guides for Nabumetone tablets can be found on the website NDC 0591-3670-01 at wvtevausa.com/medguides. The tablets are 500mg of Nabumetone, USP and should be dispensed in a light-resistant container as defined by the USP. The tablets should be kept out of reach of children and stored at 20° to 25°C (66° to 77°F). This medication is manufactured in India by Watson Pharma Private Limited and is sold by Teva Pharmaceuticals in Parsippany, NJ. This medication requires a prescription.*
Image 5
This is a medication guide for Nabumetone Tablets, USP. Each tablet contains 750mg of Nabumetone and must be dispensed in a tight, light-resistant container. The usual dosage is specified in the package insert. The medication should be stored at a temperature of 20-25°C (68-77°F) and kept out of reach of children. The medication is manufactured in India by Watson Pharma Private Limited and is distributed by Teva Pharmaceuticals. The lot number and expiration date are also provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.